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A Dicer-independent miRNA biogenesis
pathway that requires Ago catalysis
Sihem Cheloufi1,2, Camila O. Dos Santos1, Mark M. W. Chong3,4 & Gregory J. Hannon1
The nucleolytic activity of animal Argonaute proteins is deeply conserved, despite its having no obvious role in
microRNA-directed gene regulation. In mice, Ago2 (also known as Eif2c2) is uniquely required for viability, and only this
family member retains catalytic competence. To investigate the evolutionary pressure to conserve Argonaute enzymatic
activity, we engineered amousewith catalytically inactiveAgo2 alleles. Homozygousmutants died shortly after birthwith an
obvious anaemia. Examination of microRNAs and their potential targets revealed a loss of miR-451, a small RNA important
for erythropoiesis. Though this microRNA is processed by Drosha (also known as Rnasen), its maturation does not require
Dicer. Instead, the pre-miRNA becomes loaded into Ago and is cleaved by the Ago catalytic centre to generate an
intermediate 39 end, which is then further trimmed. Our findings link the conservation of Argonaute catalysis to a conserved
mechanism of microRNA biogenesis that is important for vertebrate development.
Argonaute proteins are the key effectors of small RNA-mediated regu-
latory pathways that modulate gene expression, regulate chromosome
structure and function, and provide an innate immune defence against
viruses and transposons1. The structure of Ago proteins is well con-
served, consisting of an amino-terminal domain, theMid domain, and
their signature PAZ and Piwi domains. Structure–function relation-
ships in this family are becoming increasingly well understood2. The
PAZ andMid domains help to anchor the small RNA guide, with PAZ
binding the 39 endusing a series of conserved aromatic residues and the
Mid domain providing a binding pocket for the 59 end. The Piwi
domain contains an RNase H motif that was cryptic in the primary
sequence but easily recognizable in the tertiary structure. Loading of a
highly complementary target into anAgo brings the scissile phosphate,
opposite nucleotides 10 and 11 of the small RNA guide, into the
enzyme active site, allowing cleavage of the RNA to leave 59 P and 39
OH termini3–7.
Ago proteins can be divided into three clades. The Piwi clade is
animal-specific, and forms part of an elegant innate immune system
that controls the activity ofmobile genetic elements8. TheWago clade
is specific to worms and acts in a variety of different biological pro-
cesses9. The Ago clade is defined by similarity to Arabidopsis Ago1
(ref. 10). Ago-clade proteins are found in both plants and animals
where one unifying thread is their role in gene regulation. In plants,
some Ago family members bind to microRNAs and are directed
thereby to recognize and cleave complementary target messenger
RNAs11,12.
Animal microRNAs function differently from their plant counter-
parts, with nearly all microRNA–target interactions providing insuf-
ficient complementarity to orient the scissile phosphate properly for
cleavage. Here, target recognition relies mainly on a ‘seed’ sequence
corresponding tomiRNAnucleotides 2–8. Although complementarity
of the target to other segments of the miRNA can contribute to recog-
nition, seed pairing seems to be the dominant factor in determining
regulation13. A very few extensive microRNA–target interactions can
lead to mRNA cleavage in mammals14,15. However, none of these has
yet been shown to be critical for target regulation16–18.
Despite the fact that animal microRNAs regulate targets without
Ago-mediated cleavage, the Argonaute catalytic centre is deeply con-
served. This consists of a catalytic DDH triad that serves as a metal
coordinating site19. Examining the evolution of mammalian Ago
proteins suggests a split into catalytic and non-catalytic family mem-
bers occurring early in the vertebrate lineage (results not shown). Of
the four Ago-clade proteins in mammals, only Ago2 has retained
both the DDH motif and demonstrable endonuclease activity20–22.
Ago1, Ago3 and Ago4 are linked within a single,190 kilobase locus
and have lost catalytic competence. An analysis of Ago2 mutant cells
has indicated that proteins encoded by the Ago 1/3/4 locus can sup-
port miRNA-mediated silencing20. This leaves us without a clear
explanation for the maintenance of a catalytically competent Ago
family member, because miRNAs are the exclusive partners of these
proteins in virtually all cell types20,23,24.
In mammals, endogenous small interfering RNAs have been
detected in abundance only in oocytes and embryonic stem (ES)
cells25,26 (and results not shown). In oocytes, these arise in part from
double-stranded RNAs formed from the interaction of antisense
pseudogene and sense protein-coding transcripts26,27. Loss of key
components of small RNA biogenesis or effector pathways, Dicer,
DGCR8 or Ago2, from growing oocytes indicates the importance of
endo-siRNAs for gene regulation and ultimately for proper chro-
mosome segregation in that cell type28–31. Although this phenomenon
could provide one explanation for conservation of catalysis, Ago2-
null mice are not simply female sterile. Instead, lethality is observed
from early tomid gestation20,32,33. This strongly suggests unique func-
tions for the single catalytic Ago protein outside the female germline.
We envisioned that this could be due to Ago2 being the only family
member expressed in a critical cell type or domain in the developing
embryo or to a previously unsuspected and critical role for catalysis.
Ago2 is required for extra-embryonic development
A number of studies have indicated that all four mammalian Ago
proteins share broadly similar expression patterns and largely identical
populations of bound small RNAs20,23,24,34. However, most of these
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were carried out by looking grossly at tissues of adult animals or by
using continuous cell lines. We wished to probe the possibility that
Ago2 occupies a unique expression domain during embryogenesis that
might provide an explanation for the lethal phenotype of mutations in
this gene. Towards this end, we took advantage of existing gene trap
reporters, which bring lacZ under the control of the Ago1 or Ago2
promoters. Staining of mid-gestation embryos demonstrated broad
expression of Ago2 in both the embryonic and extra-embryonic com-
partments. In contrast, Ago1 expression was restricted to the embryo
(Fig. 1a). Our previous studies also demonstrated Ago3 expression
within the developing embryo20.
Around embryonic day 8.5, the allantois grows out from the pos-
terior mesoderm of the embryo to invade the chorion. This contact is
essential for branching of the allantois structure and formation of a
complex network of blood vessels that invade the trophoblast cells to
form the labyrinthine layer. This is the site of nutrient, waste and gas
exchange between the maternal blood islands and the embryo35.
We observed growth retardation, cardiac abnormalities and aber-
rant neural tube closure in Ago2-mutant embryos previously. On the
basis of comparisons to other mutants with similar phenotypes, this
seemed strongly indicative of a defect in extra-embryonic develop-
ment36. An examination of this compartment revealed morphological
abnormalities in implanted decidua and hypotrophic placentas in
Ago2 mutants (Fig. 1b, c). Histological analysis of placental cross-
sections showed amarked reduction in the thickness of the labyrinthine
layer (Supplementary Fig. 1a). In contrast, the spongioblast and giant
trophoblast layers seemed unaffected. This was consistent with detailed
analysis of Ago2 gene trap animals, which strongly verified the presence
of the reporter in the affected cell types (Supplementary Fig. 1b).
Themalformation of the labyrinthine layer could be due either to a
failure of the embryonic vasculature to invade the placenta, or an
inherent defect in the cells derived from the trophoblast (extra-
embryonic) lineage to support the embryonic vasculature. To distin-
guish between these two possibilities, we performed tetraploid
complementation. Ago2-null ES cells were derived from mutant
embryos (Supplementary Fig. 2) and aggregated with tetraploid
cells derived from wild-type embryos. The latter can form extra-
embryonic tissues but cannot contribute to the embryo proper. One
Ago2 allele was marked by the gene-trap lacZ reporter, allowing us to
visualize the contribution of null cells to the embryo. The presence of a
wild-type extra-embryonic compartment was able to bypass the mid-
gestational death of Ago2-null embryos (Fig. 1d). This verified an
essential role for Ago2 in placental development. However, viable
mice were not obtained, indicating additional critical Ago2 functions
during later embryonic or perinatal development.
Ago2 catalytic activity is important for postnatal development
The requirement for Ago2 during embryonic development could be
based solely on it being the only Argonaute protein abundantly
expressed in critical extra-embryonic cell types or it could depend on
Ago2 being catalytically competent. We therefore sought to generate a
mouse in which Ago2 was still expressed but had been rendered cata-
lytically inactive.Wehad previously shown that substitution of alanine
for either of the two aspartate residues within the catalytic DDHmotif
disrupted RNA cleavage without impeding small RNA binding20. We
therefore replaced the endogenous Ago2 allele with one carrying an
ADH rather than a DDH triad (Supplementary Fig. 3).
We intercrossed heterozygous Ago2ADHmice and scored the ratios
of each resulting genotype at various developmental time points
(Supplementary Table 1). Expected Mendelian ratios were observed
up until the point of weaning, at which time viable homozygotes were
no longer present.
This demonstrates that Ago2 catalysis is not required for extra-
embryonic development and strongly indicates that it is simply the
presence of Ago2 as the dominant microRNA partner in this tissue
that leads to its loss-of-function phenotype.We have identifiedmany
abundant placental microRNAs that could underlie the observed
effects via their association with Ago2 (Supplementary Fig. 4).
Catalytic competence is, however, required for viability. Mice lacking
a catalytic Ago2 became pale after birth and generally died within a
few hours (Fig. 2a). Histological examination revealed no gross mor-
phological defects. However, the appearance of these animals was
strongly indicative of anaemia.
To address this possibility, we performed a complete blood count.
By embryonic day 18.5, red blood cell (RBC) counts inmutants begin
to deviate from those of control animals (Fig. 2b). This was even
more marked at birth, with mutants showing a roughly 50% reduc-
tion in peripheral RBCs. This seems specific to erythroid cells,
because no alteration in the abundance of other cell types within
the haematopoietic compartment was observed.
Loss of circulatingRBCs could result fromhaemolysis, haemorrhage,
or a defect in erythropoiesis. We therefore assessed RBC production in
the haematopoietic sites of neonates using Ter-119 and CD71 double
marking of differentiating erythroblast cell populations (Fig. 2c). We
detected a two- to threefold proportional increase in proerythroblasts
(Pro-E) in liver, bonemarrow and spleen in the AgoADH homozygotes.
These results indicated that Ago2 catalysis might be important for
erythroid maturation during the transition from pro-E to basophilic
erythroblasts.
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Figure 1 | Ago2 is essential for extra-embryonic development. a, LacZ
whole-mount staining of embryonic day 9.5 embryos bearing the Ago2gt or
Ago1gt gene trap beta-galactosidase reporter alleles and wild-type controls
(WT ctrl). b, Allelic combination in Ago2 insertional mutant embryos, with
the structure of each allele shown. HPRT, hypoxanthine-guanine
phosphoribosyl transferase gene; NEO, neomycin resistance gene; PURO,
puromycin resistance gene. c, Example wild-type (WT) and mutant
(Ago2mmc/gt) embryos from heterozygous intercrosses. Left panel:
embryonic day 10.5 embryos within their embryonic yolk sac and placentas.
Right panel: embryos dissected from their extra-embryonic components.
d, Representative embryonic day 12.5 chimaeric embryo developed from
Ago2 null ES cells aggregatedwith wild-type tetraploid embryos. From left to
right: whole chimaeric embryonic conceptus (Ago2mc/gt:WT), beta-
galactosidase staining of the whole embryo showing contribution of Ago2
null ES cells (Ago2 mc/gt), beta-galactosidase staining of the placenta showing
contribution of the ES cells to the vasculature invading the placental
labyrinth (Ago2mc/gt:WT).
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Non-canonical biogenesis of an erythropoietic miRNA
Our results indicated that miRNA-directed target cleavage might
prove important for erythrocyte maturation. As a step towards iden-
tifying such a target, we profiled miRNAs expressed in the liver, one
of the fetal haematopoietic sites. Deep sequencing from wild-type
animals and Ago2ADH homozygotes showed that virtually all
microRNAs were present at nearly identical levels. One miRNA,
miR-451, represented 11% of all miRNA reads in normal fetal liver
but was markedly reduced in the mutants (Fig. 3a).
Previous studies have demonstrated a strong dependency of the
development of pro-E into basophilic erythroblasts on the expression
of miR-451 (ref. 37). Together, miR-451 and miR-144 form a
microRNA cluster with robust expression in erythroid cells. This
pattern can be explained in part on the basis of the presence of
regulatory sites for the GATA-1 zinc finger transcription factor,
which acts as a master regulator of erythroid differentiation38. The
regulatory circuit seems to be intact in Ago2ADH animals, because we
observe no changes in the levels of precursor pre-miR-144-451 in
homozygousmutants (Fig. 3b). This strongly pointed to an impact of
catalysis on miR-451 maturation rather than miR-451 expression.
MicroRNA biogenesis occurs via a two-step processing pathway
wherein Drosha initially cleaves the primary microRNA transcript to
liberate a hairpin pre-miRNA39. This is exported to the cytoplasm and
recognized and cleaved by Dicer to yield the mature duplex, which is
loaded into Ago. The passenger strand is removed through unknown
mechanisms to yield a complex ready for target recognition.
An examination of the miR-451 precursor and its mature strand
revealed an unusual feature. As annotated, the six terminal nucleotides
of the 23-nucleotide-long mature miR-451 span the loop region and
extend into the complementary strand of the hairpin precursor. This
arrangement seems incompatible with the well-studied enzymatic
activities of Drosha and Dicer, which would normally liberate the
mature microRNA mapping to the stem only (Fig. 3c). We therefore
explored the possibility thatmiR-451might adopt an unusualmode of
biogenesis.
We began by assessing the dependency of miR-451 on Drosha. We
created a construct that drives the expression of the miR-144/451 pre-
cursor from a strong viral promoter and introduced this into mouse
embryonic fibroblasts (MEFs) homozygous for a conditional Drosha
allele.After activationofCre-ERandDrosha lossof function,wenoted a
20-fold reduction in levels of mature miR-451. This was even more
marked than the effect on a miRNA, let-7c, with a well-established
dependency on canonical processing factors (Fig. 4a). We also assessed
the ability ofDrosha to liberate pre-miR-451 in vitro. Drosha complexes
were affinity-purified from human 293T cells and mixed with in vitro-
synthesized fragments of primary pri-miR-451 or pri-miR-144. In both
cases, bands of the appropriate size for the pre-miRNA were observed
(Fig. 4b). In the case of pri-miR-451 processing the 59 flank of the
transcript folds into an additional hairpin, which may be released by
Drosha to give additional fragments. As a result, only one flank was
observed. The identities of pre-miRNAbandswere confirmedbynorth-
ernblottingwitholigonucleotideprobes corresponding to thepredicted
species (Fig. 4c, not shown). Considered together, these experiments
provide both genetic and biochemical support forDrosha catalysing the
excision of pre-miR-451 from its primary transcript.
Pre-miR-451 has an unusually short, 17-nucleotide stem region.
Previous studies indicate that this is too short to be efficiently recog-
nized and processed by Dicer40. We therefore examined the role of
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Figure 2 | Ago2 catalysis is essential for development. a, Representative
neonates from Ago2ADH heterozygous inter-crosses. WT, wild type; Mut,
Ago2 homozygous mutant. b, Peripheral blood count of litter mates from
WT and Mut. Data are the mean6 s.d. *t-test (unequal variance for
embryonic day 18.5 time point P 5 0.035, equal variance for the birth time
point P5 1.953 1027). c, Representative FACS analysis using CD71/Ter-
119 erythroid population marking of individual bone marrow samples of
mutant versus wild-type litter mates. Three independent pairs from three
different litters showed virtually identical profiles. APC, allophycocyanin;
FITC, fluorescein isothiocyanate; FACS, fluorescence-activated cell sorting.
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Dicer in miR-451 maturation. We introduced the pri-miR-451
expression vector into ES cells that are homozygous for Dicer con-
ditional alleles and express tamoxifen-inducible oestrogen receptor–
Cre fusion protein (Cre-ER). Whereas acute Dicer loss caused a
roughly 80-fold reduction in a control ES cell microRNA (miR-
294), miR-451 levels did not change (Fig. 4d). A pure population
of continuous Dicer-null ES cells showed a more than 500-fold
reduction in conventional microRNA, whereas levels of miR-451
were unaffected (Fig. 4e). We also confirmed these results using
northern blot analysis of Dicer-null ES cells transiently expressing
themiR-451 precursor (Fig. 4f). Finally, we incubated synthetic miR-
451 pre-miRNA with recombinant Dicer and observed no mature
cleavage products, although pre-let-7c was efficiently processed (not
shown). Thus, conversion of pre-miR-451 into a mature miRNA
proceeds independently of Dicer. We therefore strove to identify
an alternative maturation pathway.
We examined miR-451 species in wild-type and Ago2ADH mutant
livers by northern blotting. This confirmed loss of thematuremiRNA
in the mutant animals. However, we noted the appearance of a,40-
nucleotide band that co-migrated with a synthetic pre-miR-451 and
hybridized to probes to its 59 and 39 arms (Fig. 5a). This indicated
accumulation of the Drosha cleavage product in mutant animals.
Notably, the same bands seen in total RNA were also detected in
Ago2 immunoprecipitates (Fig. 5a). This demonstrated the direct
loading of the pre-miRNA-451 into Ago2 and raised the possibility
that the Ago2 catalytic centremight help to catalyse thematuration of
this microRNA.
The well-established biochemical properties of Ago2 predict that it
would cleave a loaded pre-miR-451 after its thirtieth base. We
searched for evidence of such an intermediate in fetal liver small
RNA libraries encompassing an expanded size range. Plotting a size
distribution of reads corresponding to a conventional miRNA, miR-
144, gave the expected pattern, a sharp peak at ,20 nucleotides. In
contrast, miR-451 showed a heterogeneous size distribution, exclu-
sively because of variation at its 39 end. One abundant species corre-
sponded precisely to the predicted Ago cleavage product (Fig. 5b, c).
We confirmed the capacity of Ago2 to load and cleave pre-miR-
451 using in vitro assays (Fig. 5d). Wild-type or catalytically inactive
Ago2 complexes (Fig. 5d) were affinity-purified from 293T cells and
mixed with 59 end-labelled pre-miR-451. Only wild-type Ago2 pro-
duced the expected product, and this depended on the presence of
Mg21 (not shown). No product was produced if we provided a
mutant version of the precursor in which a single point mutation
disrupted pairing at the cleavage site. Beta elimination and ligation
reactions confirmed that cleavage left a free 39 OH terminus as
expected of Argonaute proteins. These data strongly support a role
for the Ago2 catalytic centre in miR-451 maturation. This is perhaps
akin to the proposed role of passenger strand cleavage in the matu-
ration of RISC (RNA-induced silencing complex). Ago1 could load
pre-miR-451 but was unable to process it to its mature form (Fig. 5e)
To investigate sequence versus structural requirements for entry
into the alternative miRNA biogenesis pathway, we created a struc-
tural mimic of miR-451 that might instead produce let-7c. At the
concentration tested, this was as potent as the native pre-let-7c in
suppressing a green fluorescent protein (GFP) or luciferase reporter
containing perfect let-7c complementary sites (Fig. 5f and Sup-
plementary Fig. 5a). ThemiR-451 precursor could also be remodelled
to express a short hairpin RNA that efficiently represses p53 (also
known as Trp53; Supplementary Fig. 5b). Given the unique ability
of Ago2 to productively process miR-451, these data could have prac-
tical implications in the experimental use of shRNAs.
Considered together, our results suggest a model (Supplementary
Fig. 6) inwhichmiR-451 entersRISC through analternative biogenesis
pathway. AlthoughDrosha cleavage proceeds normally, the Dicer step
is skipped and the pre-miRNA is loaded directly into Argonaute. This
is surprising, considering earlier studies indicating a coupling of Dicer
cleavage and RISC loading41,42. Such a complex would also lack inter-
actions between the PAZ domain and the 39 end of a conventional
Dicer product43,44. A previous report indicated the ability of RISC to
accommodate such species and posited a potential for Ago cleavage in
the maturation of canonical microRNAs45. However, no physiological
role for such an activity was demonstrated, and we detect no mea-
surable defects in the processing of canonical miRNAs in Ago2ADH
mutants. miR-451 maturation proceeds with Ago-mediated cleavage,
producing an intermediate that is further trimmed. Although this
could occur via either endo- or exonucleolytic digestion, the observed
distribution of 39 ends, many bearing single non-templatedU residues
(Supplementary Figs 6, 7), seems more consistent with the latter
model. Although the precise enzymology of this step remains obscure,
preliminary studies fail to support roles for Eri-1 (also known as Eri1)
or the exosome complex (not shown).
A previous report noted severe defects in erythropoiesis in Ago2-
null cells46. In that case, the phenotype could be rescued by trans-
plantation of adult haematopoietic stem cells expressing a catalytically
inactive Ago2 allele. Although the two studies may seem at odds, we
feel that the differences simply reflect the quantitative nature of our
respective phenotypes and the fact that the strong reduction in miR-
451 that we observe results in only a partial loss of RBCs. Anaemia in
the Ago2 mutants could be a complex phenotype, of which miR-451
loss is only one component. Finally, in the earlier study, a different
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inactive Ago2 allele was expressed in adult haematopoietic stem cells
from a strong viral promoter, whereas in the work presented here, a
knock-in allele had its impact on the haematopoietic niche as a whole
during fetal development.
Although the anaemia of the Ago2ADH animals is profound, it is
unclear whether this alone is sufficient to cause the perinatal death of
mutant animals. Although no other well-defined pathologies were
observed, we did find haemorrhages in the lungs and intra-abdominal
bleeding in some animals. Moreover, miR-451 is expressed in the
gastric epithelium, where its loss could have impacts that we have as
yet failed to detect47. We leave open the possibility that additional
microRNAs might rely on the alternative biogenesis pathway for
maturation, although none presently annotated in miRBase share
the usual structure or 39 heterogeneity of miR-451. Additional defects
could also arise from a role of Ago2-mediated target mRNA cleavage.
Thus far, miR-196 and microRNAs from the imprinted Rtl1 cluster
have been ascribed this property; however, none of the phenotypes
that we observe can be explained by defects in these particular
species16–18.
The structure of the miR-451 precursor and the extension of its
mature sequence around the loop and into the complementary
strand of the precursor are present throughout vertebrate evolution
(Supplementary Fig. 8). Thus, a conserved pathway of miR-451
maturation may provide at least some of the evolutionary pressure
to maintain a catalytic Argonaute protein in animals.
METHODS SUMMARY
Mouse strains were generated as described in the Methods. Embryos were col-
lected at embryonic day 3.5 for ES cells derivation, at midgestation for embryo
phenotyping and beta-galactosidase reporter analysis, and at embryonic day 12.5
for the analysis of chimaeras. Neonates were dissected to collect peripheral blood
and haematopoietic organs (liver, bone marrow and spleen) to perform a com-
plete blood count and erythroid FACS analysis, respectively. Small RNA frac-
tions isolated from wild-type and mutant livers were cloned and deeply
sequenced as described previously48. Gene expression analysis was done by
quantitative PCR with reverse transcription (RT–PCR) using custom primers
or specific TaqMan probes. Immunoprecipitations were performed as described
in theMethods. Northern blotting of small RNAs was performed using miRNA-
specific DNA probes. In vitro Drosha, Dicer and Ago2 processing experiments
were carried out as described previously or as described in the Methods20,49. The
substrates for the enzymatic reactions were either in vitro [a32P]UTP-labelled
transcripts or [c32P]ATP end-labelled synthetic RNAs. The conditional cell lines
were treated with tamoxifen to induce gene deletion or doxycycline to induce
gene expression. All cell lines were transfected as described in the Methods and
collected for gene expression analysis or reporter assays.
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Figure 5 | Ago2 catalysis is required formiR-451 biogenesis. a, Left panels,
northern blot on total RNA fromWTandmutant livers probing for themiR-
451 guide strand and the passenger arm of the hairpin (indicated). Let-7c is
used as a loading control. Right panels, northern blots of Ago2 and IgG
control immunoprecipitates from WT and mutant liver extracts with the
indicated probes. b, miRNA read length distribution for the indicated
miRNA from deep sequencing of WT and mutant livers. c, prediction of a
miR-451 Ago2 cleavage site. Top, miR-451 39 end heterogeneity. Bottom,
predicted cleavage site at the thirtieth phosphodiester bond of pre-miR-451.
d, Left gel, in vitro cleavage assay of pre-miR-451 by an Ago2
immunoprecipitate. Right gel, confirmation of the 39 end character of the
Ago2 cleavage product using beta elimination and 39 end ligation reactions.
b, beta-eliminated; UT, untreated. e, Immunoprecipitation-northern blot
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loading of pre-miR-451 without processing in Ago1 complexes. f, Left,
schematic depictions of the pre-let-7c-miR-451 mimic hairpin compared to
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FACS analysis for GFP in the indicated samples. Cells were co-transfected
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as a transfection control and dox is doxycycline.
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METHODS
Mouse strains. Ago2 insertional mutant mouse strains, generated previously20,
were used formutant analysis, ES cell derivation and reporter analysis. Ago1 gene
trap strain was generated through germline transmission of Ago1 gene trap ES
cells from Bay Genomics (RRR031). Ago2 catalytically inactive mutant knock-in
mice were generated through germline transmission of positive ES cell clones
targeted with a bacterial artificial chromosome (RP23-56M12) that has been
modified with a point mutation D598A in the PIWI domain of Ago2.
Beta-galactosidase staining. For whole-mount staining, embryos from different
stages were dissected together with their extra-embryonic compartments in PBS.
Beta-galactosidase staining was performed using Millipore’s staining reagents.
X-gal (5-bromo-4-chloro-3-indolyl-b-D-galactoside) stainingwas performedover-
night at roomtemperature. Forplacental sections,wholeplacentaswere first stained
for beta-galactosidase, sectioned and counterstained with haematoxylin and eosin.
Ago2 mutant crosses and ES cell derivation. Ago2 mutant phenotype was re-
examined combining two insertional alleles for ease of genotyping the homo-
zygous progeny and to take advantage of the Ago2 beta-galactosidase reporter
allele. Ago2 null ES cells were derived as described previously50. Null cells were
genotyped using primers specific to both insertional alleles. Ago2mc allele:
forward (GACGGTGAAGAAGCACAGGAA), reverse (GGTCCGATGGGAA
AGTGTAGC). Ago2gt allele: forward (ATGGGATCGGCCATTGAA), reverse
(GAACTCGTCAAGAAGGCG).
RT–PCR,western blot and immunoprecipitation.Ago2RT–PCRprimers were
designed downstream of both insertional alleles: Ago2F: TGTTCCAGCA
ACCTGTCATC, Ago2R: GATGATCTCCTGTCGGTGCT. Actin primers were
used as a normalization control. ActinF: ATGCTCCCCGGGCTGTAT, ActinR:
CATAGGAGTCCTTCTGACCCATTC. Quantitative RT–PCR was performed
using Invitrogen SuperScript III and Applied Biosystems SYBR green PCR
reagent. miRNA levels were measured using Applied Biosystems pre or mature
miRNA assays. Ago2 western blot and immunoprecipitation analysis were per-
formed using Abnova anti-eif2c2 antibody (M01). P53 western was performed
using Santa Cruz mouse monoclonal antibody (Pab240).
ES-tetraploid aggregation. Ago2 null ES cells were injected into tetraploid blas-
tocyst as described previously51. Embryos were transferred to foster mothers and
dissected at embryonic day 12.5. Beta-galactosidase staining was performed as
described above.
Peripheral blood collection and FACS analysis. Blood was collected from
decapitated fetuses (pre-mortem) using heparinized microcapillaries and the
complete blood count was performed using aHemavet. For FACS analysis, single
cells were isolated from neonatal liver, spleen and bone marrow and co-stained
with Anti-Ter-119 and CD71 antibodies (BD) and analysed on LSRII flow cyt-
ometer (BD) as described previously52. The same number of events of each
sample were collected according to doublet discrimination gating and analysed
as follows: the ProE cell population was defined by CD71 high/Ter-119 medium
positive events. The Ter-119 high population was further subdivided into baso-
philic, late basophilic/polychromatic and orthochromatic/reticulocyte cell
populations according to CD71 and forward scatter parameters to define the
subsequent differentiating erythroblasts53.
Small RNA cloning and bioinformatics annotation. Total RNA was extracted
from embryonic day 18.5 livers using TRIzol. Two small RNA libraries with a size
range of 19–30 nucleotides were generated using a modified small RNA cloning
strategy48,54. Briefly, the small RNA fraction was ligated sequentially at the 39OH
and 59 phosphates with synthetic linkers, reverse transcribed and amplified using
Solexa sequencing primers. Around 7million readswere generated for each small
RNA library. Sequences were then trimmed from the 39 linker, collapsed and
mapped to the mouse genome with no mismatches using several annotation
tracks, namely: UCSC genes, miRNAs and repeats. For this study we used the
miRBase database to annotate the cloned miRNAs. Raw data and annotated
sequences of the small RNA libraries are uploaded in the GEO database (acces-
sion number GSE21370).
Cell culture, plasmids, transfections and sensor assays.miR-144-451 expression
vector was constructed by cloning the genomic cluster into pMSCV retroviral
vector. Cre-ER MEFs and ES cells were cultured as described previously50.
Excisionof theDicerandDrosha alleleswasmediated through tamoxifen treatment
(100nM) for 5 days followed by transient transfection of miR-451 expressing
plasmidusing lipofectamine (Invitrogen). For in vitroprocessing assays andnorth-
ern blots 293T cells were cultured in DMEM medium with 10% FBS serum and
cotransfected using LT-1 Mirus reagent with Flag-tagged Drosha and DGCR8
constructs,Myc-taggedAgo2orAgo1withMSCV-miR-144-451 expression vector
or Myc-tagged Ago2 alone. Dual luciferase assays were performed as described
previously. For validation of the Ago2 null ES cells, a luciferase plasmid with no
artificial site was cotransfected with a perfectly matched siRNA duplex
(Dharmacon). Testing the functionality of miR-451 mimics was performed using
three strategies: (1) cotransfection of let-7c-miR-451 mimics, pre-let-7c or let-7c
duplex or control RNAs (Dharmacon) at a 100 nM concentration with let-7c
luciferase reporter construct containing two perfect matching sites in the 39UTR
in HEK293 cells. (2) Similarly, tetracycline-inducible let-7c GFP sensor ES cells
containing two perfectly matched sites cotransfected with PE-labelled siRNA and
let-7c-miR-451 mimics (50 nM) followed by GFP analysis of PE-positive cell
population using LSRII flow cytometer (BD). GFP sensor was induced using
doxycycline (1mgml21). (3) For p53 knockdowns, ES cells were transfected with
p53 shRNAandp53-miR-451mimics followedbyp53 inductionusing adriamycin
(0.5mgml21) within the last 8 h before collection. All cells were collected 48 h
post-transfection.
Drosha and Dicer in vitro processing assays. PCR fragment mapping to miR-
451 and miR-144 were amplified out of the human genome with T7 promoter
sequence. Pre-miR-451 and pre-miR-144 RNA transcripts were generated using
the genomic PCR product and Ambion’s T7 in vitro transcription kit.
Transcripts were gel-purified and used in a Drosha in vitro processing assay as
described previously49,55. For the Dicer in vitro processing assay, 32P end-labelled
synthetic pre-miR-451 and pre-let-7c was incubated with one unit of human
recombinant Dicer (Genlantis) in 30mM Tris/HCL pH6.7, 50mM NaCl and
3mM MgCl2 buffer at 37 uC over a 4 h time course.
RNA northern blot analysis. RNA was extracted from liver homogenates and
Ago2 immunoprecipitates using TRIzol reagent. Total RNA (10–15mg) and half
of the immunoprecipitated RNA was run on a 20% acrylamide gel and trans-
ferred onto a positively charged nylon membrane (Hybond). Membranes were
crosslinked, pre-hybridized in ultra-hyb solution (Ambion) and hybridized with
32P-labelled DNA probes complementary to miR-451 and let-7c. Membranes
were washed with 23SSC, 0.1% SDS and 13SSC, 0.1% SDS buffer and exposed
on a phosphorimager screen overnight.
Ago2 cleavage assays and beta elimination. Ago2 Myc-tagged constructs (WT
and D597A) were transfected in 293T cells. Lysates were collected after 48 h,
immunoprecipitated usingMyc agarose beads. The catalysis reaction was carried
out on beads using 59 32P end-labelled synthetic pre-miR-451 (Dharmacon)
as described previously20. Beta elimination was performed by treating the
purified RNA from the Ago2 beads with sodium periodate for 30min at room
temperature followed by ethanol precipitation. The RNA was resuspended in
loading buffer containing TBE and run on a 20% acrylamide gel where the beta
elimination reaction occurs.
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